Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 1038915 60 4. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel non-enzymatic synthesis of niraparib intermediate via oxazolone route. High purity, scalable process offering significant cost reduction in API manufacturing.
Patent CN116179503A details a novel recombinant aminotransferase route for Niraparib intermediates, offering high stereoselectivity and eliminating costly chiral chromatography for supply chain efficiency.